MDMB-4en-PINACA
MDMB-4en-PINACA is a synthetic cannabinoid that has been identified in illicit products since 2019 and is sold as a designer drug. It is a potent agonist of the CB1 receptor, with a binding affinity of 0.094 nM, making it approximately 25 times more potent than THC.
History[edit | edit source]
MDMB-4en-PINACA was first identified in illicit products in 2019. It is a member of the synthetic cannabinoids family, which are a group of drugs that mimic the effects of cannabis. These substances have been associated with a number of adverse effects, including severe illness and death.
Pharmacology[edit | edit source]
MDMB-4en-PINACA is a potent agonist of the CB1 receptor, with a binding affinity of 0.094 nM. This makes it approximately 25 times more potent than THC, the primary psychoactive compound in cannabis. The effects of MDMB-4en-PINACA in humans are largely unknown, as there is very little scientific research on this substance.
Legal status[edit | edit source]
As of 2020, MDMB-4en-PINACA is a controlled substance in several countries, including the United States, the United Kingdom, and Germany. It is also listed as a Schedule I substance under the United Nations Convention on Psychotropic Substances.
See also[edit | edit source]
References[edit | edit source]
MDMB-4en-PINACA Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD